Organization
JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan
3 abstracts
Abstract
Final results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306.Org: Department of Advanced Medical Sciences, Oita University, Yufu, Japan, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Division of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan,
Abstract
A confirmatory trial of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumor diameter preoperatively estimated at 2 cm or less: Japan Clinical Oncology Group study, JCOG1101.Org: Toranomon Hospital, Tokyo Metropolitan Bokutoh Hospital, Radiation Therapy Center, Okinawa Chubu Hospital, Kagoshima University Hospital,
Abstract
A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017.Org: Okayama University Hospital, Department of Breast Oncology, Peking University Cancer Hospital, The Cancer Institute Hospital of JFCR, Tokyo, Japan, NHO Shikoku Cancer Center, Gunma Cancer Center,